MM cells have been shown to respond to a gamut of soluble growth factors and pro-survival cytokines present in the MM TME, such as IL-6, IGF-1, TNF-α, SDF-1, and BAFF, that promote drug resistance and disease progression (Hideshima et al, 2007). This evidence concerns the gene CXCL12 and Miyoshi myopathy.